Njf Capital

NJF Capital is the venture arm of NJF Holdings, deploying Nicole Junkermann’s private capital to back early-stage companies shaping the next era of innovation. Based in London with a global outlook, it invests in breakthrough technologies across healthtech, deep tech, and the broader future of human performance. With a portfolio of more than 40 companies – and a unicorn success rate exceeding 30 per cent – NJF Capital operates with clarity, speed, and long-term conviction. Its focus is not only on transformative technology, but on ventures that serve a deeper human purpose: improving health, strengthening systems, and building new forms of resilience. Within the wider NJF Holdings ecosystem – which also includes NJF Private Equity, NJF Real Estate, and NJF Sports & Media – NJF Capital partners with founders who build with substance, intention, and respect for long-term impact. It brings strategic guidance, patient capital, and a shared commitment to technologies that advance human wellbeing. Investing primarily at an early Seed to Series A stage, NJF Capital has assembled an international portfolio of more than 45 companies, of which 30 per cent are now unicorns. Our six successful exits to date include legendary disruptors Songza, Dollar Shave Club, and RelateIQ, acquired by Google, Unilever, and Salesforce respectively. Current portfolio highlights include Owkin, Cambrian Biopharma, Bolt, SpaceX and Blockchain.com.